Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy

There are few reports of conversion surgery (CS) after nivolumab monotherapy because it is considered as a third-line standard chemotherapy for unresectable or recurrent gastric cancer. Here, we report a rare case of stage IV gastric cancer effectively treated with CS after nivolumab monotherapy as...

Descripción completa

Detalles Bibliográficos
Autores principales: Watanabe, Hayato, Fujikawa, Hirohito, Komori, Keisuke, Kano, Kazuki, Takahashi, Kosuke, Yamada, Takanobu, Inokuchi, Yasuhiro, Machida, Nozomu, Yokose, Tomoyuki, Rino, Yasushi, Masuda, Munetaka, Ogata, Takashi, Oshima, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Single Case
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454226/
https://www.ncbi.nlm.nih.gov/pubmed/34616257
http://dx.doi.org/10.1159/000514396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454226/
https://www.ncbi.nlm.nih.gov/pubmed/34616257
http://dx.doi.org/10.1159/000514396

Ejemplares similares